» Articles » PMID: 30358836

FAN1 Modifies Huntington's Disease Progression by Stabilizing the Expanded HTT CAG Repeat

Overview
Journal Hum Mol Genet
Date 2018 Oct 26
PMID 30358836
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

Huntington's disease (HD) is an inherited neurodegenerative disease caused by an expanded CAG repeat in the huntingtin (HTT) gene. CAG repeat length explains around half of the variation in age at onset (AAO) but genetic variation elsewhere in the genome accounts for a significant proportion of the remainder. Genome-wide association studies have identified a bidirectional signal on chromosome 15, likely underlain by FANCD2- and FANCI-associated nuclease 1 (FAN1), a nuclease involved in DNA interstrand cross link repair. Here we show that increased FAN1 expression is significantly associated with delayed AAO and slower progression of HD, suggesting FAN1 is protective in the context of an expanded HTT CAG repeat. FAN1 overexpression in human cells reduces CAG repeat expansion in exogenously expressed mutant HTT exon 1, and in patient-derived stem cells and differentiated medium spiny neurons, FAN1 knockdown increases CAG repeat expansion. The stabilizing effects are FAN1 concentration and CAG repeat length-dependent. We show that FAN1 binds to the expanded HTT CAG repeat DNA and its nuclease activity is not required for protection against CAG repeat expansion. These data shed new mechanistic insights into how the genetic modifiers of HD act to alter disease progression and show that FAN1 affects somatic expansion of the CAG repeat through a nuclease-independent mechanism. This provides new avenues for therapeutic interventions in HD and potentially other triplet repeat disorders.

Citing Articles

Genomic and Transcriptomic Approaches Advance the Diagnosis and Prognosis of Neurodegenerative Diseases.

Liu Z, Song S Genes (Basel). 2025; 16(2).

PMID: 40004464 PMC: 11855287. DOI: 10.3390/genes16020135.


Genomic characterization of Huntington's disease genetic modifiers informs drug target tractability.

Namuli K, Slike A, Hollebeke M, Wright G Brain Commun. 2025; 7(1):fcae418.

PMID: 39801710 PMC: 11724427. DOI: 10.1093/braincomms/fcae418.


When repetita no-longer iuvant: somatic instability of the CAG triplet in Huntington's disease.

Cattaneo E, Scalzo D, Zobel M, Iennaco R, Maffezzini C, Besusso D Nucleic Acids Res. 2024; 53(1.

PMID: 39673793 PMC: 11724284. DOI: 10.1093/nar/gkae1204.


Structural and Dynamical Properties of Nucleic Acid Hairpins Implicated in Trinucleotide Repeat Expansion Diseases.

Pan F, Xu P, Roland C, Sagui C, Weninger K Biomolecules. 2024; 14(10).

PMID: 39456210 PMC: 11505666. DOI: 10.3390/biom14101278.


Poly ADP-ribose signaling is dysregulated in Huntington disease.

Maiuri T, Bazan C, Harding R, Begeja N, Kam T, Byrne L Proc Natl Acad Sci U S A. 2024; 121(40):e2318098121.

PMID: 39331414 PMC: 11459172. DOI: 10.1073/pnas.2318098121.


References
1.
Zhao X, Kumari D, Gupta S, Wu D, Evanitsky M, Yang W . Mutsβ generates both expansions and contractions in a mouse model of the Fragile X-associated disorders. Hum Mol Genet. 2015; 24(24):7087-96. PMC: 4654059. DOI: 10.1093/hmg/ddv408. View

2.
Kennedy L, Evans E, Chen C, Craven L, Detloff P, Ennis M . Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis. Hum Mol Genet. 2003; 12(24):3359-67. DOI: 10.1093/hmg/ddg352. View

3.
Mattis V, Tom C, Akimov S, Saeedian J, Ostergaard M, Southwell A . HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity. Hum Mol Genet. 2015; 24(11):3257-71. PMC: 4424959. DOI: 10.1093/hmg/ddv080. View

4.
Kaplan S, Itzkovitz S, Shapiro E . A universal mechanism ties genotype to phenotype in trinucleotide diseases. PLoS Comput Biol. 2007; 3(11):e235. PMC: 2082501. DOI: 10.1371/journal.pcbi.0030235. View

5.
Gusella J, MacDonald M, Lee J . Genetic modifiers of Huntington's disease. Mov Disord. 2014; 29(11):1359-65. DOI: 10.1002/mds.26001. View